Billiontoone (NASDAQ:BLLN) Downgraded by Wall Street Zen to Hold

Wall Street Zen lowered shares of Billiontoone (NASDAQ:BLLN) from a buy rating to a hold rating in a report issued on Saturday.

Other research analysts have also issued research reports about the company. JPMorgan Chase & Co. lowered their price target on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research report on Thursday. Guggenheim began coverage on Billiontoone in a research note on Monday, June 29th. They set a “buy” rating and a $125.00 target price on the stock. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a report on Tuesday, June 23rd. Finally, BTIG Research dropped their price target on Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research note on Thursday. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Billiontoone presently has an average rating of “Moderate Buy” and a consensus target price of $126.71.

Billiontoone Price Performance

BLLN stock opened at $93.39 on Friday. The firm’s 50-day moving average price is $116.49 and its two-hundred day moving average price is $94.28. Billiontoone has a 12-month low of $61.96 and a 12-month high of $150.44. The stock has a market capitalization of $4.30 billion and a price-to-earnings ratio of 133.41. The company has a current ratio of 11.69, a quick ratio of 10.58 and a debt-to-equity ratio of 0.17.

Billiontoone (NASDAQ:BLLN) last posted its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.15. The company had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. As a group, equities analysts predict that Billiontoone will post 0.92 earnings per share for the current year.

Insider Buying and Selling at Billiontoone

In other Billiontoone news, insider Shan Riku Sakakibara sold 4,000 shares of the firm’s stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $140.21, for a total transaction of $560,840.00. Following the completion of the transaction, the insider owned 200,000 shares of the company’s stock, valued at approximately $28,042,000. This trade represents a 1.96% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction that occurred on Monday, June 29th. The shares were sold at an average price of $120.00, for a total transaction of $169,920.00. Following the transaction, the senior vice president owned 33,552 shares of the company’s stock, valued at $4,026,240. The trade was a 4.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 202,049 shares of company stock worth $23,496,861 in the last ninety days. 50.22% of the stock is owned by company insiders.

Hedge Funds Weigh In On Billiontoone

Large investors have recently modified their holdings of the stock. Wasatch Advisors LP boosted its stake in Billiontoone by 40.2% in the 2nd quarter. Wasatch Advisors LP now owns 518,084 shares of the company’s stock worth $62,160,000 after purchasing an additional 148,446 shares in the last quarter. Thrive Wealth Management LLC purchased a new position in Billiontoone in the second quarter worth about $240,000. Perceptive Advisors LLC lifted its stake in shares of Billiontoone by 26.1% in the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company’s stock worth $7,248,000 after buying an additional 19,000 shares in the last quarter. Bank of America Corp DE grew its holdings in shares of Billiontoone by 8,603.4% during the first quarter. Bank of America Corp DE now owns 12,707 shares of the company’s stock valued at $1,003,000 after buying an additional 12,561 shares during the last quarter. Finally, The Manufacturers Life Insurance Company lifted its position in Billiontoone by 151.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 30,506 shares of the company’s stock valued at $2,408,000 after acquiring an additional 18,389 shares in the last quarter.

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.